ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript September 16, 2024

ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09.

Operator: Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies First Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in our company. Today’s call will be led by our CEO, Dr. Jennifer Bath; and our CFO,...